Redhill Biopharma
RDHL
#10269
Rank
NZ$7.39 M
Marketcap
$4.22
Share price
14.15%
Change (1 day)
-80.57%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Redhill Biopharma CIK: 0001553846
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Redhill Biopharma only files 20-F reports

Thumbnail Redhill Biopharma 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report 2021

20-F Annual Report 2021

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report 2020

20-F Annual Report 2020

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report 2019

20-F Annual Report 2019

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report 2018

20-F Annual Report 2018

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report 2017

20-F Annual Report 2017

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report

20-F Annual Report 2017-02-23

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report

20-F Annual Report 2016-02-25

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report

20-F Annual Report 2015-02-26

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report

20-F Annual Report 2014-02-25

Language: English

View Annual Report (20-F)
Thumbnail Redhill Biopharma 20-F Annual Report

20-F Annual Report 2013-02-19

Language: English

View Annual Report (20-F)